There have been many touting the tech industry as the big winner of 2020. It cannot be denied that of all the industries out there, tech has been a huge success during the pandemic. As people moved even more online — e-commerce, data management, supply chains, you name it — each and everyone took advantage.
But there was one area that also saw a boost, and for the right reasons. This industry not only is likely to continue seeing investment over the next year or more but should into the foreseeable future. The reason: COVID-19. This industry has been at the forefront of solving the problem, tackling the problem, even just surviving the problem. So, taking advantage of the success of these stocks really can only mean you’re helping bring an end to the pandemic.
What industry is that? Health care.
With that in mind, here are three stocks that will help you sleep at night, because you’ll know you’re making huge gains and helping the world in the process.
First, there’s the actual real estate itself. Across the world, hospitals and walk-in clinics have been at full capacity to help handle the pandemic. Yet this also means companies that own the properties have seen a huge increase in revenue and the renewal of lease agreements. That’s why Northwest Healthcare Properties REIT (TSX:NWH.UN) has been doing so well during the pandemic.
The company has seen year-over-year increases of 10.8% in revenue quarter after quarter. Its average lease agreement now sits at an incredible 14.5 years! As for occupancy, it remains stable and steady at a solid 97.2%. Clearly, the company isn’t going anywhere and is likely to keep expanding its footprint around the world. With a 6.2% dividend yield in the mix, you can get everything you need from this stock.
Northwest may represent the past, but CloudMD Software & Services (TSXV:DOC) represents the future. As everyone continues to remain at home, what will they do when they need basic medical treatment? If that treatment doesn’t require an in-person visit, virtual healthcare can be used as a solid substitute.
That’s where CloudMD comes in. Its telehealth services have soared in the past year, bringing in more and more acquisitions and growing its revenue by leaps and bounds — most recently, a year-over-year increase of 55%. Patients can now talk to everyone from mental health professionals to nurses. This is only going to grow even larger in the years to come, as patients can finally seek medical help from the comfort and safety of their homes.
If there’s one stock that’s likely to see a huge year and beyond, it’s going to be Pfizer (NYSE:PFE). If you’re unaware, the company created one of the first vaccines for COVID-19, believing it to be over 90% effective. After the stock fell during the crash, since then it has soared with first the announcement of the vaccine, and now with distribution starting.
This company could continue to see enormous investment now that it’s a household name. And really, it’s a great stock regardless. Shares are up 235% in the last decade alone. Revenue is still down for the last few quarters, but that’s surely to change as the world buys up vaccines. So, watch out for this stock; it’s far from finished.